Why Precision Medicine Needs an Enterprise Digital Pathology Backbone, Not Just a Vendor

Precision medicine companies are processing unprecedented molecular volumes, serving distributed health system networks, and racing to deploy AI-driven diagnostics that can meaningfully improve patient outcomes. An enterprise pathology AI platform can transform fragmented workflows into a scalable, AI-ready engine for precision medicine growth.